Detailed Information
Cited 11 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase 1/2 study of a first-in-human immune-stimulating antibody conjugate (ISAC) BDC-1001 in patients with advanced HER2-expressing solid tumors
- Authors
- Li, BT[Li, Bob T.]; Pegram, MD[Pegram, Mark D.]; Lee, KW[Lee, Keun-Wook]; Sharma, M[Sharma, Manish]; Lee, J[Lee, Jeeyun]; Spira, AI[Spira, Alexander I.]; Hanna, GJ[Hanna, Glenn J.]; Kang, YK[Kang, Yoon-Koo]; Rasco, DW[Rasco, Drew W.]; Moore, KN[Moore, Kathleen N.]; Weinberg, BA[Weinberg, Benjamin Adam]; Alonso, MN[Alonso, Michael N.]; Ptacek, J[Ptacek, Jason]; Yin, M[Yin, Ming]; Tapia, C[Tapia, Coya]; Xu, L[Xu, Lu]; Perez, EA[Perez, Edith A.]; Dumbrava, EE[Dumbrava, Ecaterina Elena]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.